While the iMAM workflow is limited to monitoring a specific number of CQAs compared to that of the bocom-up MAM approach, the requirement for little to no sample preparation results in increased turnaround time of analysis for iMAM. In addition to the analytical advantages, the workflow was designed to be cGMP compliant, using a CFR 11 certified software ensuring that data integrity is a critical aspect of the process.